Actively Recruiting
Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE
Led by China National Center for Cardiovascular Diseases · Updated on 2024-08-05
100
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aimed at comparing the performance of self-expandable valves versus balloon-expandable valves in patients with ascending aortic dilation undergoing transcatheter aortic valve replacement.
CONDITIONS
Official Title
Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Severe aortic stenosis
- Transfemoral access
- Preoperative aortic CT showing maximum ascending aortic diameter between 45mm and less than 55mm
- Anticipated life expectancy greater than 1 year
- Age 65 years or older
You will not qualify if you...
- Dominant aortic regurgitation
- History of surgical or transcatheter aortic valve replacement
- History of aortic surgery
- Emergent transcatheter aortic valve replacement
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, Beijing Municipality, China, 100037
Actively Recruiting
Research Team
K
Kang An, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here